Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam.
about
Clinical and parasitological response to oral chloroquine and primaquine in uncomplicated human Plasmodium knowlesi infectionsArtemisinin combination therapy for vivax malariaInter-allelic recombination in the Plasmodium vivax merozoite surface protein 1 gene among Indian and Colombian isolatesPyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trialFunctional analysis of Plasmodium vivax dihydrofolate reductase-thymidylate synthase genes through stable transformation of Plasmodium falciparumIn vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central EthiopiaVivax malaria: neglected and not benignDihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.Resistance to therapies for infection by Plasmodium vivaxMolecular surveillance of pvdhfr, pvdhps, and pvmdr-1 mutations in Plasmodium vivax isolates from Yunnan and Anhui provinces of ChinaPlasmodium vivax malaria endemicity in Indonesia in 2010.Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review.Monitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010.Discovery, mechanisms of action and combination therapy of artemisininIn vitro anti-malarial drug susceptibility of temperate Plasmodium vivax from central ChinaAmplification of pfmdr1, pfcrt, pvmdr1, and K13 propeller polymorphisms associated with Plasmodium falciparum and Plasmodium vivax isolates from the China-Myanmar border.History, dynamics, and public health importance of malaria parasite resistance.Confirmed Plasmodium vivax Resistance to Chloroquine in Central VietnamAn HPLC method with diode array detector for the simultaneous quantification of chloroquine and desethylchloroquine in plasma and whole blood samples from Plasmodium vivax patients in Vietnam, using quinine as an internal standard.Chloroquine resistance in Plasmodium vivax.Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India.Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.Population pharmacokinetics of a three-day chloroquine treatment in patients with Plasmodium vivax infection on the Thai-Myanmar border.Antimalarial drug therapy: the role of parasite biology and drug resistance.A Randomized Comparison of Chloroquine Versus Dihydroartemisinin-Piperaquine for the Treatment of Plasmodium vivax Infection in Vietnam.Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand.Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, EthiopiaPlasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes.Prevalence and patterns of antifolate and chloroquine drug resistance markers in Plasmodium vivax across Pakistan.Management of relapsing Plasmodium vivax malariaArtemisinin-naphthoquine combination versus chloroquine-primaquine to treat vivax malaria: an open-label randomized and non-inferiority trial in Yunnan Province, China.Plasmodium vivax multidrug resistance-1 gene polymorphism in French Guiana.Recent advances in the management of Plasmodium knowlesi infection.Early diagnosis and treatment of uncomplicated malaria and patterns of health seeking in Vietnam.Plasmodium vivax drug resistance genes; Pvmdr1 and Pvcrt-o polymorphisms in relation to chloroquine sensitivity from a malaria endemic area of Thailand.Pharmacodynamics of antimalarial chemotherapy.Border malaria associated with multidrug resistance on Thailand-Myanmar and Thailand-Cambodia borders: transmission dynamic, vulnerability, and surveillance.Malaria control in Vietnam: the Binh Thuan experience.
P2860
Q24617466-E121CBA6-A296-4922-8BCD-0F51D9F6B637Q24622539-3EF466B6-4A88-410D-B9A9-4101CAF81E77Q24804056-2FE22D29-AF90-4E01-A747-B6005437E5F5Q28476754-E3192B38-02D5-42F7-AF43-6E8BDC631588Q28481173-C0B064C0-C747-448B-AEB0-DA82E444DDBDQ28533253-A0B60153-9BFF-4C52-B960-8CC45F337E43Q29619167-3FB05614-39F8-4097-8503-E3DC20CC9CF2Q33279066-A8EB7010-93E7-44C3-998F-985F3F89FE76Q33304430-D9DD5763-3F95-4C2C-A98A-C0A5A7EB12EBQ33395221-5A7D5809-8699-4793-AC30-E8AA439FE20EQ33481576-0BF98349-69AA-487F-A41B-215D2272A4EEQ34168392-61731CAC-DE49-40C6-A0B3-DB69A923C839Q34277987-5B0CD836-747A-4A99-B057-55A1AEECFD61Q34646141-92961F26-0C51-41DB-8002-6841B330CE49Q34660024-91D2EEA3-615B-4A7C-A042-E2353A93852AQ35006418-33852C99-0272-4A2E-A95A-6D4A18FE3A7BQ35131344-06A959D8-1463-4575-A147-F82EA6E3914DQ35385310-B792812F-15A2-4B5F-9AA6-EBAC3B0A9620Q35545447-272FE878-E382-4165-963E-85A78FCB8EC2Q35782842-01173D89-7C7A-48FB-AF1A-CE230E6E8268Q35844501-90B43E3F-5B05-47CA-A878-87473F9F8711Q35927662-B1097074-8EAB-4A69-B8C0-A59E95CDAB56Q35939302-E15B2040-9371-481C-A68A-C1CC80DCE920Q36055608-BEAA4A0A-41E9-44EF-BBAE-604688E9E23FQ36634918-900A1A8E-CDF1-478B-8933-F089A8894711Q36652599-4269E92C-94DC-46B3-A9D7-2C50B342F81BQ36776130-77EEBCB2-9BB8-4A33-91D0-D50B207BBA44Q36853749-6BCD5568-00BC-4ECF-AE29-3F001D93510FQ36975316-AF7E00C8-C551-4E59-8F39-5E9CB9FC6FF6Q36993444-FBC96DCA-7219-468F-8437-9EB59954868FQ37155111-21FF6234-8EAF-4F97-B66E-0B0634E132F1Q37290599-82D48841-243F-4423-A9BB-DBD80CA2406EQ37324784-5CE238B6-CD2C-4CCA-A4DF-DE1A369D1CAFQ37402805-9CB34FE9-7F70-44DB-B89C-15AEB86BFEB6Q38842878-D4B0E030-4142-4681-88FC-40E4FDFA1BC6Q39022871-ABDC56D3-E754-479A-9615-F9C2E0003E32Q39031829-51C77B3C-9576-4521-8C7B-B14A9211D087Q41937695-0B6EEC6E-BC9D-47B4-B84D-7C23177428B2Q42181962-0213A90A-D8FD-49AD-B074-E77A7EA5CD3AQ44164329-6955076C-8497-4C90-BC6B-21EA247F9DEB
P2860
Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam.
@en
Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam.
@nl
type
label
Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam.
@en
Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam.
@nl
prefLabel
Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam.
@en
Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam.
@nl
P2093
P2860
P921
P1476
Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam.
@en
P2093
Binh Q Tran
Giao T Phan
Nam V Nguyen
Peter J de Vries
Piet A Kager
Siem H Heisterkamp
Thang V Nguyen
P2860
P304
P356
10.1046/J.1365-3156.2002.00948.X
P577
2002-10-01T00:00:00Z